Extended Data Fig. 3: Molecular Subgroup Analysis in LAPNET01.
From: Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer
a, Kaplan–Meier estimates of PFS in the LAPNET-01 cohort of 22 patients with available pre-treatment transcriptomic analysis, stratified by high and low score for Moffit’s signature based on the median. b, Kaplan–Meier estimates of OS in the LAPNET-01 cohort of 22 patients with available pre-treatment transcriptomic analysis, stratified by high and low score for Moffit’s signature based on the median. c, Kaplan–Meier estimates of PFS in the LAPNET-01 cohort of 22 patients with available pre-treatment transcriptomic analysis, stratified by high and low score for PurIST’s signature based on the median. d, Kaplan–Meier estimates of OS in the LAPNET-01 cohort of 22 patients with available pre-treatment transcriptomic analysis, stratified by high and low score for PurIST’s signature based on the median.
